Keith Goldan, SVP and CFO at Fibrocell Science, holds 52.62K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 141.73K shares in Optinose (Ticker: OPTN), holds 2.00K shares in Fibrocell Science (Ticker: FCSC). Most recently, Keith Goldan Bought ― shares of Syndax Pharmaceuticals on Jun 17, 2024 for an estimated value of 25.02K.
What is the percentage of profitable transactions made by Keith Goldan?
The percentage of profitable transactions made by Keith Goldan is 67%.
What is the average return per transaction made by Keith Goldan?
The average return per transaction made by Keith Goldan is -21.60%.
What stocks does Keith Goldan hold?
Keith Goldan holds: FCSC, OPTN, SNDX, ~PATH stocks.
What was Keith Goldan’s latest transaction?
Keith Goldan latest transaction was an Informative Buy of $25.02K.
What was Keith Goldan's most profitable transaction?
Keith Goldan’s most profitable transaction was an Informative Buy of SNDX stock on June 17, 2024. The return on the trade was 9.70%.
What is Keith Goldan's role in Fibrocell Science?
Keith Goldan's role in Fibrocell Science is SVP and CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.